Long-term clinical outcome and mortality risks after paclitaxel-coated balloon angioplasty in patients with peripheral artery disease: An observational clinical study.

The curves show a slight trend that DCB patients are more likely to be classified in Fontaine stage III/IV ( P = .136) Click here for additional data file.

also in 4,078 other papers

In this systematic review and meta‐analysis of 28 randomized controlled trials, including 4663 patients, Katsanos et al reported an “increased risk of death following the application of paclitaxel‐coated balloon and stents in the femoropopliteal artery.” 10 They also identified a “highly significant association between paclitaxel dose‐time product and the absolute risk of death.” 10 Once these results were published, there were many controversial studies that confirmed or disproved this thesis, 11 , 12 , 13 leading to a safety alert in January 2019 and further details on the im

also in 132,142 other papers